Conditions: Acral Lentiginous Melanoma
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 9
Healthy volunteers: no

Brief summary:
To determine the Overall Response Rate (ORR), as defined as rate of complete response (CR) and partial response (PR) as per RECIST 1.1 in biological treatment-naïve patients with acral lentiginous melanoma treated with pembrolizumab

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: pembrolizumab
Intervention descriptions: intervention 1: pembrolizumab at 200mg IV infusion every 3 weeks

Protocol document:
Prot_SAP_000.pdf: